Stock Screener App

Frei -

Installieren

0.439

1.75% -0.0078

Reviva Pharmaceuticals Holdings Inc (RVPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	7.11% 6.073	6.5382	6.2846	8.4625	8.1296
Operating Income/Loss	7.11% -6.073	-6.5382	-6.2846	-8.4625	-8.1296
Nonoperating Income/Loss	75.28% 0.0273	0.1105	0.0299	0.0967	0.2771
Income/Loss From Continuing Operations Before Tax	5.94% -6.0457	-6.4276	-6.2547	-8.3658	-7.8525
Income Tax Expense/Benefit	52.58% 0.00795	0.00521	0.00473	-	0.00739
Income/Loss From Continuing Operations After Tax	5.90% -6.0536	-6.4328	-6.2595	-8.3658	-7.8599
Net Income/Loss	5.90% -6.0536	-6.4328	-6.2595	-8.3658	-7.8599
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2.47% 49.85	48.64	1.723	33.80	30.56
Basic Earnings Per Share	7.69% -0.12	-0.13	-0.15	-0.25	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters